TARA CAMPO: Open Payments
NPI 1144737123 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 45 payments from 16 companies in 2025. Trend: 2023 $471 · 2024 $874 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $164 |
| ABBVIE INC. | 6 | $140 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| Novo Nordisk Inc | 5 | $89 |
| Exact Sciences Corporation | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Amgen Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
Products named: AIRSUPRA, Auvelity, The Cologuard Plus Collection Kit, QULIPTA, UBRELVY, TRELEGY ELLIPTA, Ozempic, FARXIGA.
Industry payments across IL — which companies pay providers there.
